Physician profile
Craig M Walker
NPI 1548267529
$5,010,758.67
in general payments reported to CMS, 2019-2025
80 companies · $115K in 2025
The $115K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $254K · 2020: $882K · 2021: $3.3M · 2022: $239K · 2023: $166K · 2024: $104K · 2025: $115K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $201K · Consulting Fee: $80K · Travel and Lodging: $36K · Food and Beverage: $23K · Long Term Medical Supply Or Device Loan: $17K · Honoraria: $14K · Acquisitions: $13K · Gift: $98.77 · Other payment types: $64.54.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $200,710.45 |
| Consulting Fee | $80,298.33 |
| Travel and Lodging | $36,267.63 |
| Food and Beverage | $22,729.10 |
| Long Term Medical Supply Or Device Loan | $17,083.33 |
| Honoraria | $14,300.00 |
| Acquisitions | $13,476.12 |
| Gift | $98.77 |
| Other payment types | $64.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $2,436,823.16 | 2019-2025 | Lutonix Drug Coated Balloon, Bard Urinary Drainage Bag, Rotarexs 6 F X 135 Cm |
| Anika Therapeutics, INC. | $920,023.34 | 2020-2021 | |
| Cardiva Medical, INC. | $694,017.37 | 2019-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f, Savvywire |
| Janssen Pharmaceuticals, INC | $309,761.48 | 2019-2024 | Xarelto |
| Philips North America LLC | $181,572.66 | 2019-2025 | Igt Devices Undivided, (9520) Igt Devices Undivided, US Eq Undivided |
| Boehringer Ingelheim Pharmaceuticals, INC. | $74,373.65 | 2019-2024 | Jardiance |
| Novo Nordisk INC | $57,379.20 | 2024-2025 | Ozempic, Wegovy |
| Amgen INC. | $43,500.16 | 2019-2025 | Repatha, Repatha |
| Bayer Healthcare Pharmaceuticals INC. | $34,669.85 | 2021-2025 | |
| Asahi Intecc USA, INC. | $31,690.67 | 2019-2025 | Asahi Ptca Guide Wire, Asahi Interventional Radiology Wires, Peripheral Vascular |
| Boston Scientific Corporation | $31,178.51 | 2019-2025 | Varithena Administration Pack, General - Vascular Intervention |
| Idev Technologies, INC. | $25,355.44 | 2020 | |
| Cordis US Corp. | $24,809.40 | 2022-2025 | S.M.A.R.T., Mynx Control, Radial 360 |
| Abbott Laboratories | $24,703.85 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Peripheral, Esprit |
| Angiodynamics, INC. | $21,199.19 | 2021-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro, Auryon Laser System 100-120 Vac |
Show all 71 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $20,574.17 | 2020-2024 | Nexlizet, Nexletol |
| Lilly USA, LLC | $12,317.25 | 2020-2024 | Jardiance |
| Ge Healthcare | $11,029.83 | 2021-2024 | |
| Shockwave Medical, INC | $9,592.53 | 2020-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Biotronik INC. | $8,301.32 | 2019-2023 | Pulsar-18 T3 |
| W. L. Gore & Associates, INC. | $5,075.48 | 2020-2025 | Gore Viabahn Endoprosthesis With Heparin |
| Actelion Pharmaceuticals, Ltd | $4,597.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $3,304.74 | 2020-2025 | Leqvio |
| Asahi Intecc Co., Ltd. | $3,004.99 | 2023-2025 | Crosslead, Peripheral Vascular |
| Cardiovascular Systems INC. | $2,924.34 | 2019-2023 | Diamondback Peripheral |
| Terumo Medical Corporation | $2,889.94 | 2020-2025 | Navicross, Metacross Otw, Glidewire |
| Penumbra, INC. | $2,251.51 | 2019-2025 | Penumbra System, Indigo System, Artemis |
| Avantec Vascular Corporation | $1,607.55 | 2021-2025 | |
| Janssen Scientific Affairs, LLC | $1,583.08 | 2020-2023 | Xarelto |
| Corindus INC. | $987.13 | 2019 | |
| Medtronic, INC. | $917.80 | 2021-2025 | Abre, Venaseal, In.Pact Admiral |
| Reflow Medical INC | $844.34 | 2023-2025 | |
| Cook Medical LLC | $715.61 | 2019-2023 | Zilver Ptx |
| Itamar Medical INC | $676.36 | 2021-2025 | Watchpatone |
| Tactile Systems Technology INC | $622.48 | 2022-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Veryan Medical Incorporated | $559.19 | 2021-2022 | |
| Siemens Medical Solutions USA, INC. | $506.01 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $311.01 | 2019 | |
| Endologix LLC | $309.07 | 2024-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Recor Medical INC | $302.53 | 2025 | Paradise Ultrasound Renal Denervation System |
| Surmodics, INC. | $295.98 | 2021-2024 | Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Venous Thrombectomy System |
| Pfizer INC. | $290.23 | 2019-2025 | |
| Medtronic Vascular, INC. | $274.67 | 2019-2020 | |
| Abiomed | $267.74 | 2019-2020 | |
| Celonova Biosciences, INC. | $260.71 | 2019 | |
| Vasorum USA INC. | $241.20 | 2022-2024 | Celt Acd |
| Nipro Medical Corporation | $239.09 | 2025 | Hemodialysis System |
| Venclose INC. | $230.83 | 2020 | |
| Irhythm Technologies, INC. | $158.31 | 2023 | Zio Xt Patch |
| Imperative Care, INC | $143.20 | 2024 | Symphony Catheter |
| Venturemed Group, INC. | $136.00 | 2019 | |
| Contego Medical, INC | $124.50 | 2020-2023 | |
| Zoll Respicardia, INC. | $123.75 | 2023 | Remede System |
| Mercator Medsystems, INC. | $123.18 | 2022-2024 | Leapfrog Micro-Infusion Device |
| Zoll Medical Corporation | $114.05 | 2022 | |
| Biocompatibles, INC. | $111.28 | 2019 | |
| Haemonetics Corporation | $111.15 | 2025 | Cardiva Vascade 6/7f Vcs |
| Cms Imaging, INC. | $100.97 | 2024 | |
| Inari Medical, INC. | $95.06 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Merck Sharp & Dohme LLC | $93.48 | 2022-2023 | Verquvo |
| Acutus Medical, INC. | $89.79 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $60.87 | 2024-2025 | Eliquis, Camzyos |
| Alnylam Pharmaceuticals INC. | $33.58 | 2025 | Onpattro |
| Astrazeneca Pharmaceuticals Lp | $33.29 | 2021 | |
| Kestra Medical Technology Services, INC. | $32.61 | 2025 | Assure Wcd |
| Scpharmaceuticals INC. | $25.79 | 2024 | |
| Opsens INC. | $22.14 | 2022 | |
| Amarin Pharma, INC. | $17.25 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.96 | 2025 | Lifevest |
| Silk Road Medical, INC. | $14.20 | 2022 | |
| Impulse Dynamics (USA) INC. | $12.72 | 2022 |
9 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$27,790.03 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$4,249,604.38 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.